Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Interventional × Golytely × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Personal Satisfaction 1 Colonic Neoplasms 1

Interventions

Cisplatin 626 Carboplatin 519 Paclitaxel 503 Cyclophosphamide 460 Radiotherapy 459 Docetaxel 419 Fluorouracil 395 Gemcitabine 370 Doxorubicin 349 Capecitabine 322 Dexamethasone 287 Oxaliplatin 254 Leucovorin 243 Vincristine 240 Etoposide 240 pembrolizumab 238 Bevacizumab 233 Rituximab 215 Prednisone 205 Pemetrexed 184 Cytarabine 183 Drug Therapy 174 Methotrexate 155 Trastuzumab 151 Irinotecan 144 Lenalidomide 125 Filgrastim 121 Nivolumab 116 Tamoxifen 112 Chemotherapy, Adjuvant 112

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00687830 2017-05-17

CCF

The Cleveland Clinic

Phase 3 Completed

136 enrolled 6 charts

Gastrointestinal

Colonic Neoplasms, Personal Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡